Procainamide: Clinical Trials

5 trials of Procainamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 4, Terminated 1

Follow Procainamide: new trials by email Literature Review of Procainamide trials Research Report on Procainamide

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation
Electrical-first, Chemical-first - Atrial Fibrillation
Phase 3CompletedUniversity of British Columbia862013-11-012015-06-11
AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study
FDA approved rate and rhythm control drugs, AV Node ablation and device implant - Atrial Fibrillation, Heart Failure
Phase 3TerminatedMayo Clinic272007-12-012013-04-04
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
amiodarone, sotalol, propafenone - Arrhythmia, Atrial Fibrillation
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1995-03-012016-03-25
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
amiodarone, imipramine, mexiletine - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedUniversity of Washington1987-04-012013-07-29
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
electrophysiology, electrocardiography, ambulatory, imipramine - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedUniversity of Utah1985-07-012016-01-21

Conditions studied

Arrhythmias, Cardiac (3)  ·  Atrial Fibrillation (3)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Ventricular Fibrillation (2)  ·  Death, Sudden, Cardiac (1)  ·  Heart Arrest (1)  ·  Heart Failure (1)  ·  Myocardial Infarction (1)  ·  Tachycardia, Ventricular (1)

Sponsors

Mayo Clinic (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  University of British Columbia (1)  ·  University of Utah (1)  ·  University of Washington (1)

Countries

Canada (2)  ·  United States (1)

Top investigators

H. Greene (2)  ·  Frank Scheuermeyer, MD (1)  ·  Win K Shen, MD (1)

Results publications

PMID 22032709, PMID 28974568

NIH funding

R01HL031472 (1), R01HL034071 (1)